ES546701A0 - Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa. - Google Patents

Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa.

Info

Publication number
ES546701A0
ES546701A0 ES546701A ES546701A ES546701A0 ES 546701 A0 ES546701 A0 ES 546701A0 ES 546701 A ES546701 A ES 546701A ES 546701 A ES546701 A ES 546701A ES 546701 A0 ES546701 A0 ES 546701A0
Authority
ES
Spain
Prior art keywords
therapeutic agent
neuraminidase
eventually
prepare
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES546701A
Other languages
English (en)
Other versions
ES8704082A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES546701A0 publication Critical patent/ES546701A0/es
Publication of ES8704082A1 publication Critical patent/ES8704082A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Window Of Vehicle (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
ES546701A 1984-09-06 1985-09-04 Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa. Expired ES8704082A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843432714 DE3432714A1 (de) 1984-09-06 1984-09-06 Tumortherapeutikum und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
ES546701A0 true ES546701A0 (es) 1987-03-16
ES8704082A1 ES8704082A1 (es) 1987-03-16

Family

ID=6244749

Family Applications (1)

Application Number Title Priority Date Filing Date
ES546701A Expired ES8704082A1 (es) 1984-09-06 1985-09-04 Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa.

Country Status (13)

Country Link
EP (1) EP0173951B1 (es)
JP (1) JPS6168427A (es)
AT (1) ATE64531T1 (es)
CA (1) CA1277600C (es)
DE (2) DE3432714A1 (es)
DK (1) DK172253B1 (es)
ES (1) ES8704082A1 (es)
FI (1) FI88360C (es)
GR (1) GR852149B (es)
IE (1) IE58638B1 (es)
IL (1) IL76289A (es)
PT (1) PT81093B (es)
ZA (1) ZA856807B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806565A1 (de) * 1988-03-01 1989-09-14 Deutsches Krebsforsch Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
AT398900B (de) * 1991-02-12 1995-02-27 Pekar Rudolf Dr Vakzine für eine immuntherapie
US7070782B1 (en) 1992-11-05 2006-07-04 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
US7105159B1 (en) 1992-11-05 2006-09-12 Sloan-Kettering Institute For Cancer Research Antibodies to prostate-specific membrane antigen
DE69334071T2 (de) * 1992-11-05 2007-10-25 Sloan-Kettering Institute For Cancer Research Prostata-spezifisches membranantigen
US6953668B1 (en) 1992-11-05 2005-10-11 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
US6569432B1 (en) 1995-02-24 2003-05-27 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
DE19506483A1 (de) * 1995-02-24 1996-08-29 Jens Dr Dr Atzpodien Lyophilisat-Vakzine
AU717937B2 (en) 1995-02-24 2000-04-06 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
JP5355839B2 (ja) 2001-10-23 2013-11-27 ピーエスエムエー デベロプメント カンパニー， エル．エル．シー． Ｐｓｍａ抗体およびタンパク質マルチマー
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
CN1315536C (zh) * 2002-09-13 2007-05-16 李进 肿瘤抗原疫苗及其制备方法和疫苗组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
DE2643215A1 (de) * 1976-09-25 1978-04-06 Bayer Ag Cancerostatisch wirksame praeparationen aus tumorzellen und ein verfahren zu ihrer herstellung
ZA776822B (en) * 1976-11-24 1979-06-27 D Mccollester Vaccine and method for immunotherapy of neoplastic disease
DE2918927A1 (de) * 1979-05-10 1980-11-20 Hans Prof Dr Limburg Arzneipraeparat zur behandlung von carcinomen und verfahren zu dessen herstellung
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
DE3329184A1 (de) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene
DE3416774A1 (de) * 1984-05-07 1985-11-14 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
ATE64531T1 (de) 1991-07-15
PT81093A (de) 1985-10-01
IE58638B1 (en) 1993-10-20
DK172253B1 (da) 1998-02-09
IL76289A (en) 1992-01-15
DK402485D0 (da) 1985-09-03
JPS6168427A (ja) 1986-04-08
GR852149B (es) 1986-01-03
EP0173951B1 (de) 1991-06-19
EP0173951A3 (en) 1988-06-08
FI88360B (fi) 1993-01-29
PT81093B (pt) 1988-07-01
DK402485A (da) 1986-03-07
FI853389L (fi) 1986-03-07
IL76289A0 (en) 1986-01-31
FI853389A0 (fi) 1985-09-04
CA1277600C (en) 1990-12-11
EP0173951A2 (de) 1986-03-12
FI88360C (fi) 1993-05-10
ZA856807B (en) 1986-04-30
DE3432714A1 (de) 1986-04-24
IE852191L (en) 1986-03-06
DE3583265D1 (de) 1991-07-25
ES8704082A1 (es) 1987-03-16

Similar Documents

Publication Publication Date Title
DK69890D0 (da) Monoklonale antistoffer, der er reaktive med cachetin
FI891984A7 (fi) Kineerinen vasta-aine, joka on spesifinen ihmisen kasvainantigeenille
IT1164243B (it) Composizione farmaceutica contenente almeno in parte quantitativi terapeuticamente efficaci di endotossina detossificata raffinata ed il suo impiego terapeutico
DE3584349D1 (de) Lhrh-analoga, welche die anti-lhrh-antikoerper stimulieren und diese enthaltende vakzine.
DE3880421D1 (de) Pharmazeutische zubereitungen zur behandlung der psoriasis, psoriatischen arthritis, neurodermitis und enteritis regionalis crohn.
ES527964A0 (es) Un procedimiento para preparar un vector de transferencias de adn
DE3789082D1 (de) Expression eines tumorspezifischen Antigens eines rekombinanten Virusvektors sowie dessen Anwendung zur versorgenden oder heilenden Behandlung des entsprechenden Tumors.
ES546701A0 (es) Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa.
DE3173342D1 (en) Agent for tumor localization and therapy with labeled antibodies and antibody fragments
NO965395L (no) Humane, monoklonale antistoffer som er spesifikke mot cellecyklus-uavhengig gliom-overflateantigen
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
EP0194851A3 (en) Human tumor therapy
DK314586A (da) Monoklonale antistoffer og antigener for humane lungecarcinomer, der ikke er af typen med smaa celler
ZA772648B (en) Tumor antigen and process for the preparation thereof
DE2964386D1 (en) Therapeutic means for immune complex diseases
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
EP0295305A4 (en) MONOCLONAL ANTIBODY SPECIFIC TO THE SURFACE GANGLIOSIDE OF TUMOR CELLS AND HYBRIDOMA PRODUCING THE SAME.
DK182188D0 (da) Humant tumorassocieret antigen
IL67944A0 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same
DK354288D0 (da) Kimaert antistof med specificitet over for humant tumorantigen
ATE88342T1 (de) Pharmazeutische zubereitungen zur behandlung der psoriasis, psoriatischen arthritis, neurodermitis und enteritis regionalis crohn.
IT8241523A0 (it) Agente per la conciatura del cuoio e procedimento per la sua fabbricazione.
ATE17190T1 (de) Mittel zur tumorlokalisierung und therapie mit markierten antikoerpern und antikoerperfragmenten.